Social Capital Suvretta ... (DNAB)
Social Capital Suvretta II Statistics
Share Statistics
Social Capital Suvretta II has - shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | - |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 10.3K |
| FTD / Avg. Volume | 13.29% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 40.62 and the forward PE ratio is null. Social Capital Suvretta II's PEG ratio is 0.
| PE Ratio | 40.62 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 1.05 |
| P/FCF Ratio | -839.64 |
| PEG Ratio | 0 |
Enterprise Valuation
Social Capital Suvretta II has an Enterprise Value (EV) of 257.81M.
| EV / Sales | 0 |
| EV / EBITDA | -298.82 |
| EV / EBIT | -839.22 |
| EV / FCF | -839.22 |
Financial Position
The company has a current ratio of 2.5, with a Debt / Equity ratio of 0.
| Current Ratio | 2.5 |
| Quick Ratio | 2.5 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0 |
| Debt / FCF | 0 |
| Interest Coverage | 0.24 |
Financial Efficiency
Return on Equity is 2.58% and Return on Invested Capital is -0.81%.
| Return on Equity | 2.58% |
| Return on Assets | 2.5% |
| Return on Invested Capital | -0.81% |
| Revenue Per Employee | $- |
| Profits Per Employee | $- |
| Employee Count | undefined |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -3.61M |
| Effective Tax Rate | -131.45% |
Stock Price Statistics
The stock price has increased by 0.1% in the last 52 weeks. The beta is 0, so Social Capital Suvretta II's price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | 0.1% |
| 50-Day Moving Average | 10.3 |
| 200-Day Moving Average | 10.1 |
| Relative Strength Index (RSI) | 71.96 |
| Average Volume (20 Days) | 77.48K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -862.75K |
| Net Income | 6.35M |
| EBITDA | -862.75K |
| EBIT | n/a |
| Earnings Per Share (EPS) | 0.25 |
Balance Sheet
The company has 128.65K in cash and 0 in debt, giving a net cash position of 128.65K.
| Cash & Cash Equivalents | 128.65K |
| Total Debt | 0 |
| Net Cash | 128.65K |
| Retained Earnings | -7.47M |
| Total Assets | 256.5M |
| Working Capital | -3.9K |
Cash Flow
In the last 12 months, operating cash flow was -307.2K and capital expenditures 0, giving a free cash flow of -307.2K.
| Operating Cash Flow | -307.2K |
| Capital Expenditures | 0 |
| Free Cash Flow | -307.2K |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DNAB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 2.46% |
| FCF Yield | -0.12% |
Analyst Forecast
Currently there are no analyst rating for DNAB.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 25.02 |
| Piotroski F-Score | 2 |